Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q1 2026 · 10-Q
Revenue$0.00$0.00— vs Q1 2025 Net Income-$272.61K-$272.61KN/M vs Q1 2025 EPS Diluted$0.00$0.00— vs Q1 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
-$289,274
N/M
Operating Cash Flow-$207,157N/M Free Cash Flowderived-$207,157N/M ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end